(+)-VINCRISTINE
ALK-negative Anaplastic Large Cell Lymphoma
Shanghai Jiao Tong University School of MedicineSmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 57/ 100
- Competitive Position
- 95/ 100
Competitive context
11 Active assets in the ALK-negative Anaplastic Large Cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Inno-206 City of Hope Medical Center | Phase 4 | BB |
ETOPOSIDE City of Hope Medical Center | Phase 4 | BB |
Ifosfamide Shandong Provincial Hospital | Phase 4 | BB |
PREDNISONE TABLETS Shanghai Jiao Tong University School of Medicine | Phase 4 | BB |
Cyclophosphamide Shanghai Jiao Tong University School of Medicine | Phase 4 | BB |
View all 27 →
Same molecule, other indications
(+)-VINCRISTINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →